Etanercept and Infliximab, two tumor necrosis factor-α (TNF-α) inhibitors with different action profiles: An in vitro and in vivo study in the context of reviewed therapeutic applications. | Hamdallah Zedan

Etanercept and Infliximab, two tumor necrosis factor-α (TNF-α) inhibitors with different action profiles: An in vitro and in vivo study in the context of reviewed therapeutic applications.

Citation:: Aboulwafa, M., R. Hassan, M. Abdel-Hakeem, and H. Zedan, "Etanercept and Infliximab, two tumor necrosis factor-α (TNF-α) inhibitors with different action profiles: An in vitro and in vivo study in the context of reviewed therapeutic applications.", Biointerface Research in Applied Chemistry , vol. 13, pp. 309, 2023.